112 related articles for article (PubMed ID: 9205746)
1. In vitro anti-Helicobacter pylori activity of ebrotidine.
Palacín C; Tarragó C; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):471-4. PubMed ID: 9205746
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of ebrotidine and ranitidine.
Piotrowski J; Piotrowski E; Slomiany A; Slomiany BL
J Physiol Pharmacol; 1995 Dec; 46(4):463-9. PubMed ID: 8770790
[TBL] [Abstract][Full Text] [Related]
3. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
Slomiany BL; Piotrowski J; Slomiany A
Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
[TBL] [Abstract][Full Text] [Related]
4. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer.
Popiela T; Kulig J; Karcz D; Tabor J; Torres J; Márquez M; Fillat O; Herrero E; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):573-7. PubMed ID: 9205768
[TBL] [Abstract][Full Text] [Related]
6. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of sulglycotide.
Piotrowski J; Murty VL; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1995 Mar; 35(3):467-72. PubMed ID: 7773183
[TBL] [Abstract][Full Text] [Related]
8. Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents.
Slomiany BL; Piotrowski J; Majka J; Slomiany A
Scand J Gastroenterol Suppl; 1995; 210():82-4. PubMed ID: 8578215
[TBL] [Abstract][Full Text] [Related]
9. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
Agut J; Sánchez JC; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741
[TBL] [Abstract][Full Text] [Related]
10. Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003.
Bruce MG; Bruden DL; McMahon BJ; Hennessy TW; Reasonover A; Morris J; Hurlburt DA; Peters H; Sacco F; Martinez P; Swenson M; Berg DE; Parks D; Parkinson AJ
Helicobacter; 2006 Dec; 11(6):581-8. PubMed ID: 17083381
[TBL] [Abstract][Full Text] [Related]
11. Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori.
Sunairi M; Watanabe K; Suzuki T; Tanaka N; Kuwayama H; Nakajima M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S121-4. PubMed ID: 7735928
[TBL] [Abstract][Full Text] [Related]
12. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
Palop D; Romero A; Villamayor F; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
[TBL] [Abstract][Full Text] [Related]
13. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Helicobacter pylori urease activity by ebrotidine.
Piotrowski J; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1995 Oct; 37(2):247-53. PubMed ID: 8673007
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates of Helicobacter pylori.
Alarcón T; Domingo D; Sánchez I; Sanz JC; Martínez MJ; López-Brea M
Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):275-7. PubMed ID: 9707312
[TBL] [Abstract][Full Text] [Related]
16. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children.
Agudo S; Alarcón T; Cibrelus L; Urruzuno P; Martínez MJ; López-Brea M
Rev Esp Quimioter; 2009 Jun; 22(2):88-92. PubMed ID: 19544100
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of plasma gastrin levels in rats after two months of ebrotidine administration.
Romero A; Gómez F; Villamayor F; Ballesta A; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):524-7. PubMed ID: 9205757
[TBL] [Abstract][Full Text] [Related]
18. Comparison of E-test and disk diffusion assay to evaluate resistance of Helicobacter pylori isolates to amoxicillin, clarithromycin, metronidazole and tetracycline in Costa Rica.
Lang L; García F
Int J Antimicrob Agents; 2004 Dec; 24(6):572-7. PubMed ID: 15555880
[TBL] [Abstract][Full Text] [Related]
19. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers.
Puscas I; Puscas C; Coltau M; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766
[TBL] [Abstract][Full Text] [Related]
20. [In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin].
González C; García A; Daroch F; Kawaguchi F; Solar H; Rivera N; Vega E
Rev Med Chil; 2001 Jun; 129(6):643-6. PubMed ID: 11510204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]